Stockscreener 앱 받기
4.86
1.02%
-0.05
시간 외 거래:
4.87
0.010
+0.21%
전일 마감가:
$4.91
열려 있는:
$4.86
하루 거래량:
60,735
Relative Volume:
0.34
시가총액:
$348.31M
수익:
$77.27M
순이익/손실:
$-79.00M
주가수익비율:
-4.156
EPS:
-1.1694
순현금흐름:
$-48.46M
1주 성능:
+5.65%
1개월 성능:
+0.41%
6개월 성능:
+46.39%
1년 성능:
+62.00%
1일 변동 폭
$4.63
$4.91
1주일 범위
$4.5501
$5.10
52주 변동 폭
$2.58
$5.70
Sophia Genetics Sa Stock (SOPH) Company Profile
Compare SOPH vs VEEV, TEM, BTSG, HQY, MMED
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
4.86 | 351.89M | 77.27M | -79.00M | -48.46M | -1.1694 |
|
VEEV
Veeva Systems Inc
|
185.59 | 30.25B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
48.74 | 8.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.99 | 8.27B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.13 | 6.80B | 1.29B | 191.83M | 362.67M | 2.182 |
|
MMED
Minimed Group Inc
|
17.11 | 4.71B | 0 | 0 | 0 | 0.00 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Craig Hallum | Buy |
| 2024-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | 개시 | Guggenheim | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-03 | 개시 | BTIG Research | Buy |
| 2022-11-23 | 개시 | Credit Suisse | Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-17 | 개시 | Cowen | Outperform |
| 2021-08-17 | 개시 | Credit Suisse | Outperform |
| 2021-08-17 | 개시 | JP Morgan | Overweight |
| 2021-08-17 | 개시 | Morgan Stanley | Overweight |
모두보기
Sophia Genetics Sa 주식(SOPH)의 최신 뉴스
ZHENYU XU sells shares under 10b5-1 plan (SOPH) - Stock Titan
Jurgi Camblong (SOPH) reports multiple 10b5-1 sales across late 2025–2026 - Stock Titan
Trend Report: Can SOPHiA GENETICS SA continue delivering strong returns2026 Risk Factors & Stock Portfolio Risk Management - baoquankhu1.vn
Growth Recap: Why is SOPHiA GENETICS SA stock going downTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn
SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Decrease in Short Interest - MarketBeat
[144] SOPHiA GENETICS SA SEC Filing - Stock Titan
[EFFECT] SOPHiA GENETICS SA SEC Filing - Stock Titan
Sophia Genetics Earnings Call: Growth Surges, Losses Linger - TipRanks
Aug PreEarnings: Can SOPHiA GENETICS SA stock double in the next yearJuly 2025 Momentum & High Yield Equity Trading Tips - baoquankhu1.vn
SOPHiA GENETICS (SOPH) Q4 Loss Deepens And Reinforces Bearish Profitability Concerns - Sahm
Will SOPHiA GENETICS SA stock go up in YEARQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
SOPHiA GENETICS Q4 Earnings Call Highlights - Defense World
Sophia Genetics SA (SOPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
SOPH SEC FilingsSophia Genetics Sa 10-K, 10-Q, 8-K Forms - Stock Titan
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q4 2025 Earnings Call Transcript - Insider Monkey
BTIG Maintains Buy on SOPHiA GENETICS S.A. (SOPH) March 03, 2026 - Meyka
SOPHiA GENETICS (NASDAQ: SOPH) registers 75,000 warrant shares for resale - Stock Titan
BTIG reiterates Sophia Genetics stock rating on customer growth - Investing.com
Fulgent Genetics (FLGT) Earnings Transcript - AOL.com
SOPHiA GENETICS S.A. Q4 2025 Earnings Call Summary - Yahoo Finance
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 - Finviz
SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript - The Globe and Mail
SOPHiA GENETICS SA reports results for the quarter ended December 31Earnings Summary - TradingView
SOPHiA GENETICS SA 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-03-03 - Seeking Alpha
SOPHiA GENETICS (NASDAQ:SOPH) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS - MarketBeat
Sophia Genetics reports fourth quarter and full year 2025 results - marketscreener.com
SOPHiA GENETICS (SOPH) 2025 20-F flags losses, platform and regulatory risks - Stock Titan
[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC FilingForm 6-K - Stock Titan
Sophia Genetics Q4 Earnings Summary & Key TakeawaysSophia Genetics (NASDAQ:SOPH) - Benzinga
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results - PR Newswire
A Look at Sophia Genetics's Upcoming Earnings ReportSophia Genetics (NASDAQ:SOPH) - Benzinga
SOPHiA GENETICS (SOPH) to Release Earnings on Tuesday - Defense World
SOPH Should I Buy - Intellectia AI
SOPHiA GENETICS SA expected to post a loss of 24 cents a shareEarnings Preview - TradingView
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Expands By 194.3% - MarketBeat
Why The SOPHiA GENETICS (SOPH) Narrative Is Shifting On Richer Valuation And Growth Expectations - Yahoo Finance UK
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference - Finviz
SOPHiA GENETICS CEO, president in TD Cowen fireside chat March 4 - Stock Titan
SOPHiA GENETICS (SOPH) Projected to Announce Earnings on Tuesday - MarketBeat
Zhenyu Xu files Rule 144 for SOPH (NASDAQ: SOPH) citing multiple 10b5-1 sales - Stock Titan
Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million - AOL.com
Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough - AOL.com
AI medicine firm SOPHiA GENETICS lines up March 3 earnings call - Stock Titan
Swiss–Japanese Partnership Advances Precision Oncology through Liquid Biopsy and Companion Diagnostics - S-GE
Can SOPHiA GENETICS SA continue delivering strong returns2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
Aug Patterns: Will SOPHiA GENETICS SA stock go up in YEARQuarterly Performance Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
Moderna Just Crushed Estimates While Everyone Was Looking the Other Way - AOL.com
Can SOPHiA GENETICS SA (90B) stock deliver double digit returnsJobs Report & Free Safe Capital Growth Stock Tips - mfd.ru
Is SOPHiA GENETICS SA a potential multi baggerJuly 2025 Outlook & Free Fast Gain Swing Trade Alerts - mfd.ru
Why The Story Behind SOPHiA GENETICS (SOPH) Is Shifting After The Latest Target Reset - Yahoo Finance
Sophia Genetics Sa (SOPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.94%
자본화:
|
볼륨(24시간):